These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8406942)
21. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. Bolt HM; Foth H; Hengstler JG; Degen GH Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638 [TBL] [Abstract][Full Text] [Related]
22. Estimating exposure and dose to characterize health risks: the role of human tissue monitoring in exposure assessment. Sexton K; Callahan MA; Bryan EF Environ Health Perspect; 1995 Apr; 103 Suppl 3(Suppl 3):13-29. PubMed ID: 7635107 [TBL] [Abstract][Full Text] [Related]
23. Optimal Exposure Biomarkers for Nonpersistent Chemicals in Environmental Epidemiology. Calafat AM; Longnecker MP; Koch HM; Swan SH; Hauser R; Goldman LR; Lanphear BP; Rudel RA; Engel SM; Teitelbaum SL; Whyatt RM; Wolff MS Environ Health Perspect; 2015 Jul; 123(7):A166-8. PubMed ID: 26132373 [TBL] [Abstract][Full Text] [Related]
24. Exposure assessment implications for the design and implementation of the National Children's Study. Ozkaynak H; Whyatt RM; Needham LL; Akland G; Quackenboss J Environ Health Perspect; 2005 Aug; 113(8):1108-15. PubMed ID: 16079086 [TBL] [Abstract][Full Text] [Related]
25. Studies using specific biomarkers for human exposure assessment to exogenous and endogenous chemical agents. Farmer PB Mutat Res; 1999 Jul; 428(1-2):69-81. PubMed ID: 10517980 [TBL] [Abstract][Full Text] [Related]
26. Mammary gland neoplasia in long-term rodent studies. Russo IH; Russo J Environ Health Perspect; 1996 Sep; 104(9):938-67. PubMed ID: 8899375 [TBL] [Abstract][Full Text] [Related]
27. Approaches to environmental exposure assessment in children. Weaver VM; Buckley TJ; Groopman JD Environ Health Perspect; 1998 Jun; 106 Suppl 3(Suppl 3):827-32. PubMed ID: 9646045 [TBL] [Abstract][Full Text] [Related]
28. Monitoring of human populations for early markers of cadmium toxicity: a review. Fowler BA Toxicol Appl Pharmacol; 2009 Aug; 238(3):294-300. PubMed ID: 19433102 [TBL] [Abstract][Full Text] [Related]
29. Biomonitoring and biomarkers of organophosphate pesticides exposure - state of the art. Kapka-Skrzypczak L; Cyranka M; Skrzypczak M; Kruszewski M Ann Agric Environ Med; 2011; 18(2):294-303. PubMed ID: 22216802 [TBL] [Abstract][Full Text] [Related]
31. Embryo toxicity and teratogenicity of formaldehyde. Thrasher JD; Kilburn KH Arch Environ Health; 2001; 56(4):300-11. PubMed ID: 11572272 [TBL] [Abstract][Full Text] [Related]
32. The use of biomarkers for risk assessment: Reporting from the INTARESE/ENVIRISK Workshop in Prague. Smolders R; Bartonova A; Boogaard PJ; Dusinska M; Koppen G; Merlo F; Sram RJ; Vineis P; Schoeters G Int J Hyg Environ Health; 2010 Sep; 213(5):395-400. PubMed ID: 20538520 [TBL] [Abstract][Full Text] [Related]
33. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents. Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708 [TBL] [Abstract][Full Text] [Related]
34. Evaluating legacy contaminants and emerging chemicals in marine environments using adverse outcome pathways and biological effects-directed analysis. Hutchinson TH; Lyons BP; Thain JE; Law RJ Mar Pollut Bull; 2013 Sep; 74(2):517-25. PubMed ID: 23820191 [TBL] [Abstract][Full Text] [Related]
35. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate. Hasegawa R; Koizumi M; Hirose A Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717 [TBL] [Abstract][Full Text] [Related]
36. A toxicologist's guide to biomarkers of hepatic response. Amacher DE Hum Exp Toxicol; 2002 May; 21(5):253-62. PubMed ID: 12141396 [TBL] [Abstract][Full Text] [Related]
37. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
38. From dermal exposure to internal dose. Van de Sandt JJ; Dellarco M; Van Hemmen JJ J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S38-47. PubMed ID: 17440485 [TBL] [Abstract][Full Text] [Related]
39. Biological indicators of genotoxic risk and metabolic polymorphisms. Pavanello S; Clonfero E Mutat Res; 2000 Oct; 463(3):285-308. PubMed ID: 11018745 [TBL] [Abstract][Full Text] [Related]
40. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]